Bortezomib and daratumumab in refractory autoimmune hemolytic anemia. McGlothlin J, Abeykoon J, Al-Hattab E, Ashrani AA, et al. Am J Hematol 2023 Jul 7. doi: 10.1002/ajh.27025.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McGlothlin J, Abeykoon J, Al-Hattab E, Ashrani AA, et al. Bortezomib and daratumumab in refractory autoimmune hemolytic anemia. Am J Hematol 2023 Jul 7. doi: 10.1002/ajh.27025.
PMID: 37417424